Please enable JavaScript to continue using this application.

Compare $EBS vs $FENC | Chartloom

Compare

$EBS vs $FENC

Emergent BioSolutions Inc · Fennec Pharmaceuticals Inc

EBS

Emergent BioSolutions Inc

FENC

Fennec Pharmaceuticals Inc

Compare $EBS vs $FENC

Comparing Emergent BioSolutions Inc and Fennec Pharmaceuticals Inc

EBSEmergent BioSolutions Inc

FENCFennec Pharmaceuticals Inc

EBSEmergent BioSolutions Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-9.6%

YTD performance

-43.6%

52W performance

-28.6%

FCF yield

9.7%

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EBS

FENC

Detailed metrics comparison

EBS

Emergent BioSolutions Inc

FENC

Fennec Pharmaceuticals Inc

Market Cap

EBS$364M

FENC$372M

Enterprise Value

EBS$806M

FENC$331M

Price

EBS$7.06

FENC$10.71

P/E Ratio

EBSN/A

FENCN/A

P/S Ratio

EBS0.47x

FENC6.28x

EV/Sales

EBS1.05x

FENC5.59x

EV/EBITDA

EBS3.65x

FENC111.97x

P/B Ratio

EBS0.95x

FENC8.43x

P/FCF Ratio

EBS10.26x

FENCN/A

EV/FCF

EBS22.72x

FENC-162.16x

PEG Ratio

EBSN/A

FENCN/A

Forward P/E (NTM)

EBSN/A

FENC18.55x

Forward P/S (NTM)

EBSN/A

FENC4.23x

Revenue (TTM)

EBS$770M

FENC$59M

Revenue Growth (YoY)

EBS-9.6%

FENC77.8%

Forward Rev Growth

EBS7.1%

FENC42.8%

Gross Margin (TTM)

EBS55.8%

FENC93.7%

Operating Margin (TTM)

EBS0.0%

FENC0.0%

EBITDA Margin (TTM)

EBS28.7%

FENC-1.9%

Net Margin (TTM)

EBS-23.0%

FENC-5.5%

FCF Margin (TTM)

EBS4.6%

FENC-3.4%

Net Income (TTM)

EBS$-177M

FENC$-3M

FCF (TTM)

EBS$36M

FENC$-2M

EPS (TTM)

EBS-$3.43

FENC-$0.09

ROE (TTM)

EBS-3591.0%

FENC-678.0%

ROA (TTM)

EBS-1356.0%

FENC-486.0%

ROIC (TTM)

EBS-1622.0%

FENC-678.0%

Cash

EBS$140M

FENC$41M

Debt

EBS$582M

FENC$0

Net Cash/Debt

EBS$-442M

FENC$41M

Current Ratio (TTM)

EBS5.42x

FENC5.85x

Quick Ratio (TTM)

EBS2.74x

FENC5.36x

Debt/Equity (TTM)

EBS1.70x

FENC0.00x

Debt/Assets (TTM)

EBS0.0%

FENC0.0%

Interest Coverage (TTM)

EBSN/A

FENCN/A

Net Debt/EBITDA (TTM)

EBS0.00x

FENC0.00x

Beta

EBS2.42

FENC1.21

52W Performance

EBS-28.6%

FENC16.2%

YTD Performance

EBS-43.6%

FENC39.5%

% from 52W High

EBS-49.8%

FENC-19.2%

% from 52W Low

EBS61.9%

FENC89.6%

Asset Turnover (TTM)

EBS0.59x

FENC0.89x

FCF Yield (TTM)

EBS9.7%

FENC-0.5%

Earnings Yield (TTM)

EBS-48.5%

FENC-0.9%

Dividend Yield (TTM)

EBSN/A

FENCN/A

Rule of 40

EBS-4.9

FENC74.4

EV/GP/RG

EBS0.27

FENC0.12

Ticker research

View EBS research View FENC research

Metric	EBS Emergent BioSolutions Inc	FENC Fennec Pharmaceuticals Inc
Market & Valuation
Market Cap	$364M	$372M
Enterprise Value	$806M	$331M
Price	$7.06	$10.71
P/E Ratio	N/A	N/A
P/S Ratio	0.47x	6.28x
EV/Sales	1.05x	5.59x
EV/EBITDA	3.65x	111.97x
P/B Ratio	0.95x	8.43x
P/FCF Ratio	10.26x	N/A
EV/FCF	22.72x	-162.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	18.55x
Forward P/S (NTM)	N/A	4.23x
Revenue & Growth
Revenue (TTM)	$770M	$59M
Revenue Growth (YoY)	-9.6%	77.8%
Forward Rev Growth	7.1%	42.8%
Profitability
Gross Margin (TTM)	55.8%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	28.7%	-1.9%
Net Margin (TTM)	-23.0%	-5.5%
FCF Margin (TTM)	4.6%	-3.4%
Net Income (TTM)	$-177M	$-3M
FCF (TTM)	$36M	$-2M
EPS (TTM)	-$3.43	-$0.09
ROE (TTM)	-3591.0%	-678.0%
ROA (TTM)	-1356.0%	-486.0%
ROIC (TTM)	-1622.0%	-678.0%
Financial Health
Cash	$140M	$41M
Debt	$582M	$0
Net Cash/Debt	$-442M	$41M
Current Ratio (TTM)	5.42x	5.85x
Quick Ratio (TTM)	2.74x	5.36x
Debt/Equity (TTM)	1.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.21
52W Performance	-28.6%	16.2%
YTD Performance	-43.6%	39.5%
% from 52W High	-49.8%	-19.2%
% from 52W Low	61.9%	89.6%
Efficiency & Yields
Asset Turnover (TTM)	0.59x	0.89x
FCF Yield (TTM)	9.7%	-0.5%
Earnings Yield (TTM)	-48.5%	-0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	74.4
EV/GP/RG	0.27	0.12
Ticker research	View EBS research	View FENC research

Valuation

P/S Ratio

EBS

0.47x

FENC

6.28x

EV/FCF

FENC

-162.16x

EBS

22.72x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

EBS

-9.6%

Forward Revenue Growth

FENC

42.8%

EBS

7.1%

Profitability & performance

Gross Margin

FENC

93.7%

EBS

55.8%

ROE

FENC

-678.0%

EBS

-3591.0%

FCF Yield %

EBS

9.7%

FENC

-0.5%

52-Week Performance

FENC

16.2%

EBS

-28.6%

Detailed metrics comparison

EBS

Emergent BioSolutions Inc

FENC

Fennec Pharmaceuticals Inc

Market Cap

EBS$364M

FENC$372M

Enterprise Value

EBS$806M

FENC$331M

Price

EBS$7.06

FENC$10.71

P/E Ratio

EBSN/A

FENCN/A

P/S Ratio

EBS0.47x

FENC6.28x

EV/Sales

EBS1.05x

FENC5.59x

EV/EBITDA

EBS3.65x

FENC111.97x

P/B Ratio

EBS0.95x

FENC8.43x

P/FCF Ratio

EBS10.26x

FENCN/A

EV/FCF

EBS22.72x

FENC-162.16x

PEG Ratio

EBSN/A

FENCN/A

Forward P/E (NTM)

EBSN/A

FENC18.55x

Forward P/S (NTM)

EBSN/A

FENC4.23x

Revenue (TTM)

EBS$770M

FENC$59M

Revenue Growth (YoY)

EBS-9.6%

FENC77.8%

Forward Rev Growth

EBS7.1%

FENC42.8%

Gross Margin (TTM)

EBS55.8%

FENC93.7%

Operating Margin (TTM)

EBS0.0%

FENC0.0%

EBITDA Margin (TTM)

EBS28.7%

FENC-1.9%

Net Margin (TTM)

EBS-23.0%

FENC-5.5%

FCF Margin (TTM)

EBS4.6%

FENC-3.4%

Net Income (TTM)

EBS$-177M

FENC$-3M

FCF (TTM)

EBS$36M

FENC$-2M

EPS (TTM)

EBS-$3.43

FENC-$0.09

ROE (TTM)

EBS-3591.0%

FENC-678.0%

ROA (TTM)

EBS-1356.0%

FENC-486.0%

ROIC (TTM)

EBS-1622.0%

FENC-678.0%

Cash

EBS$140M

FENC$41M

Debt

EBS$582M

FENC$0

Net Cash/Debt

EBS$-442M

FENC$41M

Current Ratio (TTM)

EBS5.42x

FENC5.85x

Quick Ratio (TTM)

EBS2.74x

FENC5.36x

Debt/Equity (TTM)

EBS1.70x

FENC0.00x

Debt/Assets (TTM)

EBS0.0%

FENC0.0%

Interest Coverage (TTM)

EBSN/A

FENCN/A

Net Debt/EBITDA (TTM)

EBS0.00x

FENC0.00x

Beta

EBS2.42

FENC1.21

52W Performance

EBS-28.6%

FENC16.2%

YTD Performance

EBS-43.6%

FENC39.5%

% from 52W High

EBS-49.8%

FENC-19.2%

% from 52W Low

EBS61.9%

FENC89.6%

Asset Turnover (TTM)

EBS0.59x

FENC0.89x

FCF Yield (TTM)

EBS9.7%

FENC-0.5%

Earnings Yield (TTM)

EBS-48.5%

FENC-0.9%

Dividend Yield (TTM)

EBSN/A

FENCN/A

Rule of 40

EBS-4.9

FENC74.4

EV/GP/RG

EBS0.27

FENC0.12

Ticker research

View EBS research View FENC research

Metric	EBS Emergent BioSolutions Inc	FENC Fennec Pharmaceuticals Inc
Market & Valuation
Market Cap	$364M	$372M
Enterprise Value	$806M	$331M
Price	$7.06	$10.71
P/E Ratio	N/A	N/A
P/S Ratio	0.47x	6.28x
EV/Sales	1.05x	5.59x
EV/EBITDA	3.65x	111.97x
P/B Ratio	0.95x	8.43x
P/FCF Ratio	10.26x	N/A
EV/FCF	22.72x	-162.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	18.55x
Forward P/S (NTM)	N/A	4.23x
Revenue & Growth
Revenue (TTM)	$770M	$59M
Revenue Growth (YoY)	-9.6%	77.8%
Forward Rev Growth	7.1%	42.8%
Profitability
Gross Margin (TTM)	55.8%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	28.7%	-1.9%
Net Margin (TTM)	-23.0%	-5.5%
FCF Margin (TTM)	4.6%	-3.4%
Net Income (TTM)	$-177M	$-3M
FCF (TTM)	$36M	$-2M
EPS (TTM)	-$3.43	-$0.09
ROE (TTM)	-3591.0%	-678.0%
ROA (TTM)	-1356.0%	-486.0%
ROIC (TTM)	-1622.0%	-678.0%
Financial Health
Cash	$140M	$41M
Debt	$582M	$0
Net Cash/Debt	$-442M	$41M
Current Ratio (TTM)	5.42x	5.85x
Quick Ratio (TTM)	2.74x	5.36x
Debt/Equity (TTM)	1.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.21
52W Performance	-28.6%	16.2%
YTD Performance	-43.6%	39.5%
% from 52W High	-49.8%	-19.2%
% from 52W Low	61.9%	89.6%
Efficiency & Yields
Asset Turnover (TTM)	0.59x	0.89x
FCF Yield (TTM)	9.7%	-0.5%
Earnings Yield (TTM)	-48.5%	-0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	74.4
EV/GP/RG	0.27	0.12
Ticker research	View EBS research	View FENC research